Greater China
China's Genesis targets $1.2b for Fund III
Genesis Capital, a China growth-stage technology investor established by Richard Peng, who previously led the investment program at Tencent Holdings, is seeking $1.2 billion for its third US dollar-denominated fund.
Q&A: IPV Capital's Alex Banh
Semiconductors are a popular investment target in China on the back of US decoupling and a push for self-sufficiency. Alex Banh, a managing partner of sector specialist IPV Capital, shares his views
China regulatory crackdown threatens PE education deals
China has imposed severe restrictions on private tutoring that appear to undermine the commercial viability of companies in the space, potentially making private equity investment unviable.
CPE joins Series D for China biotech player TransThera
TransThera, a China-based drug developer, has raised $100 million in Series D funding led by CPE and China Structural Reform Fund.
China autonomous driving developer CalmCar raises $150m
CalmCar, a China-based provider of self-driving solutions, has closed a $150 million Series C round led by German auto parts supplier ZF Group. The company is targeting an IPO in 2022.
Sequoia leads $150m Series E for AIOps player Cloudwise
Cloudwise, a Beijing-based artificial intelligence operations (AIOps) provider, has raised $150 million in Series E funding led by Sequoia Capital China.
China DNA sequencing start-up gets $116m Series C
Chinese next-generation sequencing (NGS) player Geneplus Technology has raised a RMB750 million ($116 million) Series C round led by China Construction Bank’s venture unit CCB International.
Black Ant, GenBridge lead Series B for China coffee chain
M Stand - a China-based coffee shop chain with ambitions to become the Starbucks for China's younger generation - has raised RMB500 million ($77 million) in Series B funding led by Black Ant Capital and GenBridge Capital.
China petcare brand raises $31m
Chongxing, a Chinese petcare brand, has raised RMB200 million ($31 million) in a third tranche of Series B funding from Tencent Holdings, Hony Capital, HighLight Capital, Vertex Ventures China, and Meridian Capital.
Hong Kong sees rush of VC-backed biotech IPO filings
Five VC-backed pre-revenue Chinese biotech companies have filed to list in Hong Kong over the past two weeks, doubling the size of the IPO pipeline in this category.
Hong Kong-based crypto exchange FTX raises $900m
FTX, a Hong Kong-headquartered cryptocurrency exchange, has raised $900 million in Series B funding at a valuation of $18 billion, up from $1.2 billion on closing the Series A last year.
Ince hits $450m first close on second China VC fund
Ince Capital, a Chinese venture capital firm established by J.P. Gan, formerly a managing partner at Qiming Venture Partners, has achieved a first close of approximately $450 million on its second fund.
Taiwan video SaaS start-up raises $16m Series B
Kdan Mobile Software, a Taiwanese software-as-a-service company focused on corporate video and design services, has raised a $16 million Series B round featuring WI Harper Group.
China beauty: Service with a smile
Beauty and wellness are at the vanguard of China’s fast-rising services sector. Investors see clear paths to growth, but size presents a plethora of problems in terms of standardizing service quality
Deal focus: Neiwai realizes value offline
Vertex Ventures China was adamant that Neiwai should expand offline on leading a Series B for the lingerie brand in 2017. Four years and two rounds later, the strategy is paying off
Capital Today leads $35m Series B for China's XYZ Robotics
Capital Today China Group has led a $35 million Series B round for XYZ Robotics, a Chinese start-up specializing in robotic hand-eye coordination.
PatPat raises $510m across Series C, D rounds
PatPat, a Chinese-founded children’s wear brand that claims to be the world’s largest direct-to-consumer (DTC) player in its segment, has raised $510 million across two rounds of funding.
China's Meiwei Dental raises $150m
China’s Meiwei Dental Group has raised a RMB1 billion ($150 million) Series B round from Fortune Capital, TFTR Investment, and local conglomerate New Hope Group.
Tech investment surges in India, SE Asia as China plummets
A drop-off in PE and VC technology investment in China in the second quarter of 2021 – widely linked to a multi-faceted regulatory crackdown on the sector – was to some extent counterbalanced by record levels of activity in India and Southeast Asia.
Sherpa Healthcare leads Series A for Paq Therapeutics
Sherpa Healthcare Partners has led a $30 million Series A for Paq Therapeutics, a Chinese-founded biotech company specializing in treatments based on molecules that enhance the degradation of disease-causing entities.
Carlyle leads $100m Series D for Chinese lingerie brand
Chinese lingerie brand Neiwai has raised a $100 million Series D round led by The Carlyle Group. Vertex Ventures China and Qiming Venture Partners re-upped.
GGV, Tiger Global lead $50m round for China bakery brand
Tiger Attitude, a China-based bakery brand, has raised a $50 million Series A round led by GGV Capital and Tiger Global. Both IDG Capital and Sequoia Capital China re-upped, having participated in a pre-Series A in January alongside Challenjers Capital....
Hong Kong last-mile delivery player Gogox raises $100m
Gogox, a Hong Kong-headquartered last-mile logistics company formerly known as GoGoVan, has raised $100 million in funding led by the international arm of China Bank of Communications and Cyberport Macro Fund.
China drug developer Adlai Nortye gets $100m Series D
Adlai Nortye, a Chinese biopharma player specializing in cancer treatments, has raised $100 million in Series D funding.